Evidence map›Paper›PMID 30894609›Full record

ArticleScientific reports2019

An engineered GH1 β-glucosidase displays enhanced glucose tolerance and increased sugar release from lignocellulosic materials.

Clelton A Santos, Mariana A B Morais, Oliver M Terrett, Jan J Lyczakowski, Letícia M Zanphorlin, Jaire A Ferreira-Filho, Celisa C C Tonoli, Mario T Murakami, Paul Dupree, Anete P Souza

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Overexpression of theInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Profiling of the β-glucosidases identified in the genome ofApplied and environmental microbiology · 2023
    Article
  9. Review
  10. Engineering cellulases for conversion of lignocellulosic biomass.Protein engineering, design & selection : PEDS · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Clelton A SantosCentro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, SP, Brazil.ORCID 0000-0002-6725-8925
Mariana A B MoraisLaboratório Nacional de Ciência e Tecnologia do Bioetanol, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, SP, Brazil.
Oliver M TerrettUniversity of Cambridge, Department of Biochemistry, Cambridge, UK.
Jan J LyczakowskiUniversity of Cambridge, Department of Biochemistry, Cambridge, UK.ORCID 0000-0002-7694-8629
Letícia M ZanphorlinLaboratório Nacional de Ciência e Tecnologia do Bioetanol, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, SP, Brazil.
Jaire A Ferreira-FilhoCentro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Celisa C C TonoliLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, SP, Brazil.
Mario T MurakamiLaboratório Nacional de Ciência e Tecnologia do Bioetanol, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, SP, Brazil.
Paul DupreeUniversity of Cambridge, Department of Biochemistry, Cambridge, UK.ORCID 0000-0001-9270-6286
Anete P SouzaCentro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, SP, Brazil. anete@unicamp.br.ORCID 0000-0003-3831-9829
Laboratório Nacional de Ciência e Tecnologia do Bioetanol · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Cambridge · GB

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J014540/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/M015432/1
6 · The paper itself

Abstract

β-glucosidases play a critical role among the enzymes in enzymatic cocktails designed for plant biomass deconstruction. By catalysing the breakdown of β-1, 4-glycosidic linkages, β-glucosidases produce free fermentable glucose and alleviate the inhibition of other cellulases by cellobiose during saccharification. Despite this benefit, most characterised fungal β-glucosidases show weak activity at high glucose concentrations, limiting enzymatic hydrolysis of plant biomass in industrial settings. In this study, structural analyses combined with site-directed mutagenesis efficiently improved the functional properties of a GH1 β-glucosidase highly expressed by Trichoderma harzianum (ThBgl) under biomass degradation conditions. The tailored enzyme displayed high glucose tolerance levels, confirming that glucose tolerance can be achieved by the substitution of two amino acids that act as gatekeepers, changing active-site accessibility and preventing product inhibition. Furthermore, the enhanced efficiency of the engineered enzyme in terms of the amount of glucose released and ethanol yield was confirmed by saccharification and simultaneous saccharification and fermentation experiments using a wide range of plant biomass feedstocks. Our results not only experimentally confirm the structural basis of glucose tolerance in GH1 β-glucosidases but also demonstrate a strategy to improve technologies for bioethanol production based on enzymatic hydrolysis.

Indexed as

beta-GlucosidaseCatalytic DomainEscherichia coliEthanolFermentationGlucoseHydrolysisLigninMutagenesis, Site-DirectedTrichodermabeta-GlucosidaseEthanolGlucoseLigninlignocellulose

Identifiers

PMID30894609
PMCPMC6426972
OpenAlexW2922955108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.